HER-2/NEU EXPRESSION IN PROSTATE CANCER: HIGH LEVEL OF EXPRESSION ASSOCIATED WITH EXPOSURE TO HORMONE THERAPY AND ANDROGEN INDEPENDENT DISEASE

Abstract

High HER-2/neu expression is highly associated with exposure to hormone therapy and androgen independence. It may contribute to androgen independence in prostate cancer and identify patients with prostate cancer more likely to have disease progression, particularly those not exposed to previous hormone therapy.